About: proliferative diabetic retinopathy

Facets (new session)
Description
Metadata
Settings
- owl:sameAs
- Inference Rule:

About: proliferative diabetic retinopathy Goto Sponge NotDistinct Permalink

An Entity of Type : wikibase:Item, within Data Space : wikidata.demo.openlinksw.com associated with source document(s)

Human disease

Attributes	Values
rdf:type	Item
description	Krankheit (de) Human disease (en) хвороба людини (uk) مرض يصيب الإنسان (ar)
exact match	wds:Q18967481-081F1907-9F41-4B0F-B886-C8A8AA660687 wds:Q18967481-C861A742-2810-472F-8872-EE9F3EB58B0D
exact match	http://purl.obolibrary.org/obo/DOID_13207 http://identifiers.org/doid/DOID:13207
Experimental Factor Ontology ID	wds:Q18967481-434D2576-D976-467D-8DEC-D266A595A873
health specialty	wds:Q18967481-A2870558-19FA-49E3-8D16-68E743F79021
Mondo ID	wds:Q18967481-17A8B218-D067-41C0-8488-C5E7B8F9E0E0
Disease Ontology ID	wds:Q18967481-73C3E431-B7BB-46D4-AF62-D81AF88AF932
Mondo ID	http://purl.obolibrary.org/obo/MONDO_0001660
Disease Ontology ID	http://purl.obolibrary.org/obo/DOID_DOID:13207
Experimental Factor Ontology ID	0009322
health specialty	neurology
Mondo ID	MONDO_0001660
Disease Ontology ID	DOID:13207
rdfs:label	proliferative diabetic retinopathy (en) proliferativna diabetična retinopatija (sl) rétinopathie diabétique proliférante (fr)
skos:prefLabel	proliferative diabetic retinopathy (en) proliferativna diabetična retinopatija (sl) rétinopathie diabétique proliférante (fr)
name	proliferative diabetic retinopathy (en) proliferativna diabetična retinopatija (sl) rétinopathie diabétique proliférante (fr)
instance of	wds:Q18967481-CEB142BF-6401-4939-B393-CC3D8492E10E
instance of	class of disease
subclass of	wds:Q18967481-620BE1F9-69E0-4DE0-9ACD-EE03B93B86C8
subclass of	diabetic retinopathy
ICD-9-CM	wds:Q18967481-0628FECA-8179-4C26-A02F-75C1C05B7A16
ICD-9-CM	362.02
skos:altLabel	PDR (en) PDR (sl)
NCI Thesaurus ID	wds:Q18967481-7EEDDB48-D41D-4DF3-8106-812518A45B28
UMLS CUI	wds:Q18967481-6634D52D-DE1F-42CA-A58E-D1D01830CFB4
on focus list of Wikimedia project	wds:Q18967481-8F500E8A-A1FE-4A77-AE7F-B06E01F5B7E6
ICD-11 ID (MMS)	wds:Q18967481-0cdc1a2c-9670-4f49-ba05-dbba9d5c6526
ICD-11 (foundation)	wds:Q18967481-FBFE22BC-E861-4936-A22B-9D8C7AD79462
NCI Thesaurus ID	C84457
UMLS CUI	C0154830
on focus list of Wikimedia project	WikiProject Medicine
ICD-11 ID (MMS)	9B71.01
ICD-11 (foundation)	348602398
is about of	https://www.wikidata.org/wiki/Special:EntityData/Q18967481
is main subject of	wds:Q125252756-4f4bcc41-4859-ea2b-2a5c-c75635e76cdc
is main subject of	Combined modified grid and panretinal photocoagulation for diffuse diabetic macular edema and proliferative diabetic retinopathy Erythropoietin concentrations in the vitreous body from patients with proliferative diabetic retinopathy Regression of iris neovascularization after intravitreal injection of bevacizumab in patients with proliferative diabetic retinopathy Proliferative diabetic retinopathy: vitreo-retinal complications are often related to insufficient retinal photocoagulation Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision. Clinical application of results of a randomized trial--Diabetic Retinopathy Vitrectomy Study Report 4. The Diabetic Retinopathy Vitrectomy Study Research Grou The negative coincidence of retinitis pigmentosa and proliferative diabetic retinopathy Elevation of serum IGF-1 precedes proliferative diabetic retinopathy in Mauriac's syndrome Free insulin growth factor-I and vascular endothelial growth factor in the vitreous fluid of patients with proliferative diabetic retinopathy A clinical comparison of central and peripheral argon laser panretinal photocoagulation for proliferative diabetic retinopathy Homocysteine levels in the vitreous of proliferative diabetic retinopathy and rhegmatogenous retinal detachment: its modulating role on lysyl oxidase Effects of bevacizumab on the neovascular membrane of proliferative diabetic retinopathy: reduction of endothelial cells and expressions of VEGF and HIF-1α. The results of intravitreal bevacizumab injections for persistent neovascularizations in proliferative diabetic retinopathy after photocoagulation therapy Expression of Pigment Epithelium-Derived Factor and Vascular Endothelial Growth Factor in Fibrovascular Membranes from Patients with Proliferative Diabetic Retinopathy Intravitreous vascular endothelial growth factor and hypoxia-inducible factor 1a in patients with proliferative diabetic retinopathy Intravitreal bevacizumab (Avastin) treatment of proliferative diabetic retinopathy complicated by vitreous hemorrhage Effect of retinal coagulation status on oxidative metabolite and VEGF in 208 patients with proliferative diabetic retinopathy Proliferative diabetic retinopathy: predictive and preventive measures at hypoxia induced retinal changes Management of proliferative diabetic retinopathy Intravitreal bevacizumab (Avastin) prevention of panretinal photocoagulation-induced complications in patients with severe proliferative diabetic retinopathy Long-term review of driving potential following bilateral panretinal photocoagulation for proliferative diabetic retinopathy SPARC is a major secretory gene expressed and involved in the development of proliferative diabetic retinopathy Expression of Robo4 in the fibrovascular membranes from patients with proliferative diabetic retinopathy and its role in RF/6A and RPE cells. Expression of integrins in human proliferative diabetic retinopathy membranes Differences of ocular circulation in eyes with proliferative diabetic retinopathy after panretinal photocoagulation with and without rubeosis iridis Intravitreal bevacizumab (Avastin) for proliferative diabetic retinopathy: 6-months follow-up. Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy Plasma and vitreous homocysteine concentrations in patients with proliferative diabetic retinopathy Local and genetic determinants of vascular endothelial growth factor expression in advanced proliferative diabetic retinopathy TCF7L2 variation and proliferative diabetic retinopathy Polymorphisms of the UCP2 gene are associated with proliferative diabetic retinopathy in patients with diabetes mellitus. Evidence for control of tumour necrosis factor-alpha (TNF-alpha) activity by TNF receptors in patients with proliferative diabetic retinopathy Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy The -106CC genotype of the aldose reductase gene is associated with an increased risk of proliferative diabetic retinopathy in Caucasian-Brazilians with type 2 diabetes Elevated gamma-aminobutyric acid, glutamate, and vascular endothelial growth factor levels in the vitreous of patients with proliferative diabetic retinopathy Light panretinal photocoagulation (LPRP) versus classic panretinal photocoagulation (CPRP) in proliferative diabetic retinopathy Abnormally Low or High Ankle-Brachial Index Is Associated with Proliferative Diabetic Retinopathy in Type 2 Diabetic Mellitus Patients PROLIFERATIVE DIABETIC RETINOPATHY: EVOLUTION OF THE RETINAL LESIONS The role of photocoagulation in the therapy of proliferative diabetic retinopathy A comparative trial of xenon arc and argon laser photocoagulation in the treatment of proliferative diabetic retinopathy Importance of the localization of the photocoagulation focus in the therapy of proliferative diabetic retinopathy Treatment of proliferative diabetic retinopathy with panretinal cryotherapy The effectiveness of photocoagulation in the therapy of proliferative diabetic retinopathy (PDR). (A controlled study in 50 patients). Cryoretinopexy for proliferative diabetic retinopathy Increased vitreous shedding of microparticles in proliferative diabetic retinopathy stimulates endothelial proliferation Retinal venular diameter as an early indicator of progression to proliferative diabetic retinopathy with and without high-risk characteristics in African Americans with type 1 diabetes mellitus Glutamic acid decarboxylase autoantibody prevalence and association with HLA genotype in patients with younger-onset type 1 diabetes and proliferative diabetic retinopathy Increased levels of platelet-derived growth factor in vitreous fluid of patients with proliferative diabetic retinopathy Relationship of diabetic microvascular complications to outcome in panretinal photocoagulation treatment of proliferative diabetic retinopathy Platelet expression of tumour necrosis factor-alpha (TNF-alpha), TNF receptors and intercellular adhesion molecule-1 (ICAM-1) in patients with proliferative diabetic retinopathy Positive correlation of pigment epithelium-derived factor and total antioxidant capacity in aqueous humour of patients with uveitis and proliferative diabetic retinopathy Rapid resolution of severe disc new vessels in proliferative diabetic retinopathy following a single intravitreal injection of bevacizumab (Avastin) Circulating tissue-type plasminogen activator and plasminogen activator inhibitor type 1 in proliferative diabetic retinopathy: a pilot study

Faceted Search & Find service v1.16.117 as of May 05 2024

Alternative Linked Data Documents: ODE Content Formats:

RDF

ODATA

Microdata

About

OpenLink Virtuoso version 07.20.3239 as of May 5 2024, on Linux (x86_64-centos_6-linux-gnu), Single-Server Edition (378 GB total memory, 190 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software